They have to put those caveats in. SEC and all ya
Post# of 72440
Sure, people can criticize the decision to PR it. But those who understand what CTIX's drugs are aimed at understand that the company is basically saying "here's the confirmation that Brilacidin is a powerful anti-inflammatory." They're telling the astute that Bril-OM works too.